Daiichi Sankyo Co. Ltd.

In News

Daiichi Sankyo (OTCMKTS:DSNKY) Trading Down 4.3% - Here's What Happened - MarketBeat

MarketBeat - Dec 19, 2025

Daiichi wins appeal of $42 million US verdict in Enhertu patent case - Reuters

Reuters - Dec 02, 2025

Daiichi Sankyo is leveraging Azure OpenAI Service to develop generative AI and foster an AI-friendly culture - Microsoft

Microsoft - May 02, 2025

DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy - Business Wire

Business Wire - Dec 18, 2025

Daiichi Sankyo, AstraZeneca apply for second EU approval for Datroway - marketscreener.com

marketscreener.com - Dec 18, 2025

Market Outlook: Why analysts recommend Daiichi Sankyo Company Limited (D4S) stock - 2025 Short Interest & AI Driven Price Predictions - Улправда

Улправда - Dec 20, 2025

Japan’s Daiichi Sankyo Shares Drop After Discounted Block Trades - Bloomberg.com

Bloomberg.com - Aug 21, 2025

Daiichi Sankyo Showcases Strength of Industry-Leading ADC Portfolio with Latest Research Updates from Five Landmark Breast Cancer Trials at SABCS - BioSpace

BioSpace - Dec 09, 2025

Earnings call transcript: Daiichi Sankyo Q2 2025 misses EPS forecast, stock drops - Investing.com

Investing.com - Oct 31, 2025

AstraZeneca, Daiichi's breast cancer drug gets FDA nod as first-line treatment - Reuters

Reuters - Dec 15, 2025

Immuto Scientific announces financing, Daiichi Sankyo collab - BioWorld MedTech

BioWorld MedTech - Sep 18, 2025

Effect of Rifampicin on the Pharmacokinetics of Valemetostat and Its Primary Metabolite: A Phase 1 Study in Healthy Participants - Wiley

Wiley - Jul 07, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment